• Disodium bicinchoninate for Endothelial Assays

  2026-09-14

  Disodium bicinchoninate provides an aqueous route for protein normalization in endothelial stress workflows without a DMSO or ethanol vehicle. This guide translates an H2O2-induced HUVEC study into practical assay design, reagent preparation, quality controls, and troubleshooting steps for mechanistic cell biology.

• Iptacopan (LNP023): Complement Assay Workflows

  2026-09-13

  Iptacopan (LNP023) gives researchers a selective, reversible way to isolate alternative-pathway biology without broadly suppressing complement. This guide translates its factor B mechanism into practical hemolysis, C3 deposition, serum, and disease-model workflows, with optimization advice for reproducible complement activation research.

• Cyclic di-GMP: Biofilm and STING Workflows

  2026-09-12

  Cyclic di-GMP connects bacterial persistence biology with STING-focused immune modulation research. This practical guide translates its antitoxin and STING agonist roles into biofilm, biochemical, and cancer immunotherapy studies while emphasizing preparation, controls, and troubleshooting.

• Anti Reverse Cap Analog for High-Expression mRNA

  2026-09-11

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, gives in vitro transcription workflows orientation-specific Cap 0 mRNA with approximately twofold higher translation than conventional m7G capping. This article connects cap optimization with LNP delivery, including the IL-10 mRNA strategy used to study poststroke microglia and blood–brain barrier repair.

• Anti Reverse Cap Analog for Synthetic mRNA

  2026-09-11

  Anti Reverse Cap Analog (ARCA) enables orientation-controlled 5′ capping for high-expression synthetic mRNA workflows. Its value is especially clear in transient cell-fate programming, where reliable translation can improve repeated delivery strategies without genomic integration.

• DMXAA (Vadimezan) Workflow for Tumor Models

  2026-09-10

  DMXAA (Vadimezan) supports complementary tumor-cell, endothelial, enzymatic, and formulation-based assays. This workflow connects vascular disruption and VEGFR2-related signaling with a recent nuclear-targeted nanorod strategy that uses DMXAA to amplify DNA damage and STING-associated innate immunity.

• ARL4C and Macrophage Dynamics in Rheumatoid Arthritis

  2026-09-10

  The reference study integrates single-cell and bulk transcriptomics with cellular co-culture and collagen-induced arthritis experiments to position ARL4C as a regulator of aggressive fibroblast-like synoviocyte behavior in rheumatoid arthritis. Its findings connect ARL4C-dependent synoviocyte proliferation and invasion with macrophage polarization, while suggesting that local ARL4C silencing may help reduce inflammatory and cartilage-damaging phenotypes.

• Tofacitinib Citrate in Translational JAK Research

  2026-09-09

  Tofacitinib citrate is more than a JAK3-directed research reagent: used with concentration-aware immune and endothelial assays, it can reveal why cytokine suppression does not necessarily predict vascular protection.

• GPX4 and Platinum Resistance in Lung Cancer Brain Metastasis

  2026-09-09

  Liu and colleagues identified a glutathione-consuming, ferroptosis-suppressive program that gives lung cancer-derived brain metastatic cells acquired resistance to platinum drugs. Their integrated model places Wnt/NR2F2-dependent GPX4 transcription upstream of this metabolic adaptation, suggesting that GPX4-directed interventions could improve platinum responses while highlighting the need for brain-metastasis-specific validation.

• Human iPSC Intestinal Organoids for Pharmacokinetics

  2026-09-08

  Saito and colleagues established a direct 3D cluster-culture approach for generating expandable, cryopreservable intestinal organoids from human induced pluripotent stem cells. The resulting organoids produce differentiated intestinal epithelial cells with cytochrome P450 and transporter activities, creating a more human-relevant platform for intestinal absorption and drug-metabolism studies.

• Reversine: Aurora Kinase Inhibitor Workflow

  2026-09-08

  Reversine is a practical chemical probe for connecting Aurora kinase signaling pathway activity with mitotic failure, checkpoint behavior, and cancer-cell phenotypes. This workflow emphasizes dose design, orthogonal readouts, formulation control, and careful separation of Aurora-driven effects from Plk1-regulated checkpoint mechanisms.

• Perospirone in Schizophrenia Research

  2026-09-07

  Perospirone (SM-9018 free base) combines 5-HT2A and D2 receptor antagonism with 5-HT1A partial agonism, making it a versatile tool for schizophrenia research and neuropsychiatric disorder models. New evidence that it inhibits vascular Kv1.5-associated currents adds a practical cardiovascular safety and ion-channel dimension to assay design.

• DRP1, Mitochondrial Fission, and ATII Cell Glycolysis

  2026-09-07

  Sun et al. show that hyperoxia activates DRP1-associated mitochondrial fission in alveolar type II cells and is accompanied by a shift toward aerobic glycolysis. Using neonatal rats, primary ATII cells, RLE-6TN cells, Seahorse metabolic analysis, and pharmacological inhibition, the study connects mitochondrial dynamics with metabolic remodeling relevant to bronchopulmonary dysplasia.

• Tivozanib (AV-951): VEGFR Inhibition Guide

  2026-09-05

  Tivozanib, also called AV-951, is a potent and selective VEGFR tyrosine kinase inhibitor with reported 160 pM activity against VEGFR-2. Its profile supports mechanistic studies of anti-angiogenic therapy, renal cell carcinoma treatment, and quantitative drug-response workflows.

• Sharper Western Blots for Macrophage Inflammation

  2026-09-04

  Mechanism-driven atherosclerosis studies depend on more than a strong band: they require controlled, reproducible evidence connecting Olfr2, calcium-dependent ROS, NHE1, and inflammatory responses. This thought-leadership guide explains how a Western Secondary Antibody Dilution Buffer can support cleaner protein detection, improve antibody handling, and strengthen translational interpretation without overstating what immunoblotting can prove.

8515 records 1/568 page Next 12345 下5页 Last page